Zocere Given Top Innovator Award by youngStartup Ventures
POSTED: April 17, 2014
NEW YORK CITY, N.Y., April 17, 2014 – - youngStartup Ventures has presented Zocere, Inc., a New Mexico-based pharmaceutical company developing a novel, biologic-based neuroprotectant drug, with its Top Innovator Award, which recognizes private companies driving the future of innovation. The award was given at the 2014 Life Sciences & Venture Summit held April 2 in New York City.
Zocere is a New Mexico-based pharmaceutical company focused on creating drug-based treatments for neurological diseases, with the most compelling data to date for the treatment of stroke. Currently, there are few treatment options for blood clot-induced ischemic stroke, which accounts for 87 percent of strokes. Treatments currently on the market are little used and have risks associated with their use. Zocere’s STEP protein, a cell-permeable, recombinant peptide, shows promise as a potent “brain saving” drug when administered post stroke. It also shows potential for treating other brain trauma, including concussion.
As one of the Top Innovators chosen by Young Startup, Wayne Laslie, president and CEO of Zocere, presented the company at the exclusive 2014 Life Sciences & Healthcare Venture Summit on April 2 at the Digital Sandbox, where a select group of 350 entrepreneurs, investors, and corporate developers gathered to be the first to meet this next wave of leading edge companies.
Laslie said Zocere was honored to be included among the elite group of youngStartup Ventures Top Innovator Award recipients. “We are very excited about our stroke drug technology and believe it has the potential to transform how patients who have experienced an ischemic stroke are treatment and dramatically improve patient outcomes. It is gratifying that youngStartup Ventures realizes the potential of Zocere.”
To honor Top Innovator Award recipients, youngStartup Ventures has invited their CEOs and founders to present at The New York Venture Summit, June 16-17. The annual Summit is a forum for exciting early stage and emerging growth companies, and allows leaders to share insights on the future of innovation and the entrepreneurial journey. Held at the Digital Sandbox, this intimate, invitation-only conference is the premier venue for today’s promising startups.
About Zocere, Inc.
Headquartered in Albuquerque, New Mexico, Zocere is a pharmaceutical company developing injectable neuroprotectant drugs intended to combat stroke and other neurological trauma. Zocere is led by pharmaceutical industry executives with extensive experience in drug commercialization. Visit www.Zocere.com.